US FDA Races To List Essential Medicines For Domestic Manufacture By White House Deadline
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?
With list due 4 November, there may not be time for public comment. Meanwhile, where will biopharma find fill/finish capacity?